URGN UroGen Pharma Ltd.

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies.

$8.73  +0.16 (1.87%)
As of 12/01/2022 16:00:00 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  Israel
IPO date:  05/04/2017
Outstanding shares:  23,090,039
Average volume:  68,941
Market cap:   $197,881,634
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ7PJQ1
Valuation   (See tab for details)
PE ratio:   -1.78
PB ratio:   23.28
PS ratio:   6.65
Return on equity:   663.45%
Net income %:   -380.92%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy